2-amidobenzothiazoles as cb1 receptor inverse agonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/428 (2006.01) A61P 3/04 (2006.01) C07D 277/82 (2006.01)

Patent

CA 2528785

The present invention relates to compounds of formula (I) wherein R1, R2, R3, R3a and R3b are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.

La présente invention concerne des composés de formule (I), dans laquelle R?1¿, R?2¿, R?3¿, R?3a¿ et R?3b¿ sont tels que définis dans le mémorandum descriptif et dans les revendications, et des sels pharmaceutiquement acceptables desdits composés, destinés à être utilisés comme substances pharmaceutiquement actives. Les composés de l'invention sont utiles pour le traitement et/ou la prophylaxie de maladies associées à la modulation du récepteur CB1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-amidobenzothiazoles as cb1 receptor inverse agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-amidobenzothiazoles as cb1 receptor inverse agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amidobenzothiazoles as cb1 receptor inverse agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1800151

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.